about
Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer[Validation and clinical application of MammaPrint® in patients with breast cancer].Systematic review of HER2 breast cancer testing.Expression profiling of rectal tumors defines response to neoadjuvant treatment related genes.Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.Expression inactivation of SMARCA4 by microRNAs in lung tumorsHER2 status in breast cancer: experience of a Spanish National Reference Centre.BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines.SWI/SNF proteins as targets in cancer therapy.Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas.Biomedical application of fuzzy association rules for identifying breast cancer biomarkers.Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: a Spanish case-control study.Preoperative chemoradiotherapy for rectal cancer: the sensitizer role of the association between miR-375 and c-Myc.Real-time RT-PCR analysis for evaluating the Her2/neu status in breast cancer.Allelic expression and quantitative RT-PCR study of TAp73 and DeltaNp73 in non-Hodgkin's lymphomas.Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes.Differential expression of NF-κB pathway genes among peripheral T-cell lymphomasGene expression analysis of chromosomal regions with gain or loss of genetic material detected by comparative genomic hybridizationExpression of the NF-κB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectivelyA haplotype containing thep53polymorphisms Ins16bp and Arg72Pro modifies cancer risk inBRCA2mutation carriersCoincidental LOH regions in mouse and humans: evidence for novel tumor suppressor loci at 9q22?q34 in non-Hodgkin?s lymphomasIdentification of a Proliferation Signature Related to Survival in Nodal Peripheral T-Cell LymphomasFrequent inactivation of thep73gene by abnormal methylation or LOH in non-Hodgkin's lymphomas[Stem cells treatment for patients with heart diseases]Expression of the long non-coding RNA TCL6 is associated with clinical outcome in pediatric B-cell acute lymphoblastic leukemiaCorrection to: BRG1 regulation by miR-155 in human leukemia and lymphoma cell linesExpression of Concern: BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines
P50
Q26778557-58055BD7-B3AF-4810-A2BE-817BB03D20A4Q30981689-41BA0AAA-B4EB-4000-96A7-7AB67FD497FAQ33358376-A8F269B5-60F0-40E8-B493-41F2979711B4Q34473018-8C918EEB-0CE3-4045-BF7F-A73DC66302ACQ34989668-949A5360-E1F3-4DE2-8FE2-57483B3DB642Q35063165-DEAABB4E-2D28-4326-98D7-1516C6A3DE9CQ37877415-10911EE1-46A2-4B1E-96C8-E49335305D2EQ38714250-33E79C2A-B44F-4644-9278-3F801E338A20Q42260609-3DBE6C41-46D4-4080-913F-22585FAA02A9Q43793379-FD843003-6F75-4017-94AF-5B57C8F98104Q46736635-3373096F-6484-414B-9479-9E1217D87C6BQ46943875-B7613251-DBC1-43C6-AD1E-BD87CDF402CDQ47111822-CE22690B-529F-456A-967A-D702BC26D795Q54439817-5A16D658-A1FE-4D65-8C06-DAEF4FF528D8Q54650046-E70C75AC-B7AC-46D7-85C5-E2F3E6C9312BQ54707035-2B6E6DD4-ECF7-411F-AECB-53316BA534C2Q57279479-9341B371-BF5A-46B6-ABC1-DF6AF3D27630Q57837779-B7CA2077-3A7A-4C4C-87D4-77F4251CB120Q58010962-850DA733-A142-403C-ADCA-ECA2ACBA03B6Q59539012-1E309EC0-183A-4A4A-8FD3-85B9020B30F0Q60895665-EDA47718-62CF-4E7E-8766-74DB628EA626Q61822347-8C5B008D-03E2-4121-8A70-B67BA0FAE019Q61822354-F473CB17-490B-4E64-AB1A-E555D37997A1Q83009574-0927E8BB-DD01-407B-9634-D1FD6C668913Q91451384-17776113-04CD-47AB-84B6-8C891ABB2134Q92216575-EB433159-E340-4CA6-B733-0815054EFED8Q92216583-353D94CC-05C7-4F8F-B7C3-F24783949221
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marta Cuadros
@ast
Marta Cuadros
@en
Marta Cuadros
@es
Marta Cuadros
@nl
Marta Cuadros
@sl
type
label
Marta Cuadros
@ast
Marta Cuadros
@en
Marta Cuadros
@es
Marta Cuadros
@nl
Marta Cuadros
@sl
prefLabel
Marta Cuadros
@ast
Marta Cuadros
@en
Marta Cuadros
@es
Marta Cuadros
@nl
Marta Cuadros
@sl
P106
P1153
55912976600
P21
P2456
P31
P496
0000-0002-8329-4854